Frequently asked questions and answers about Moderna COVID-19 vaccine | Bangkok Hospital
Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures | NEJM
COVID-19 Vaccine Boosters vs. Third Doses: Frequently Asked Questions - Anne Arundel County Department of Health
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
Hawaii State Department of Health - What vaccine options are available for 16 & 17 year olds? The Pfizer vaccine is currently the only vaccine authorized for people under age 18. The
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
Getting the Second COVID-19 Vaccine Dose If You're Immunocompromised
COVID-19 Vaccine Authorized and Recommended for Children Under 5 - NACCHO
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
CDC updates COVID-19 vaccine recommended wait time to eight weeks for some groups | Children's Minnesota
What Does a Multi-Dose Series Mean for the COVID-19 Vaccination Effort? | KFF
Untitled
Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine | Nature Communications
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December
Phases and Eligibility
Evaluation of COVID-19 vaccination strategies with a delayed second dose | medRxiv
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine
What is the evidence for extending the SARS-CoV-2 (COVID-19) vaccine dosing schedule? | British Columbia Medical Journal
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
SECOND DOSE TIMING SECOND DOSE LOCATION SECOND DOSE BRAND
ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine | Australian Government Department of Health and Aged Care
Missouri Department of Health & Senior Services on Twitter: "You may have heard that you don't have to quarantine after you receive a COVID-19 vaccine. Here is a breakdown of timing for
